Home
AMPH
AMPH News

Latest Amphastar Pharmaceuticals Inc. (AMPH) News on April 24, 2025

Argus Research

2 days ago

AMPH: What does Argus have to say about AMPH?

MT Newswires

3 days ago

BofA Adjusts Price Target on Amphastar Pharmaceuticals to $31 From $36

Argus Research

9 days ago

AMPH: What does Argus have to say about AMPH?

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth?

Insider Monkey

9 days ago

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth?

2 Reasons to Like AMPH and 1 to Stay Skeptical

StockStory

9 days ago

2 Reasons to Like AMPH and 1 to Stay Skeptical

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Simply Wall St.

13 days ago

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Argus Research

16 days ago

AMPH: Lowering target price to $26.00

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

ACCESS Newswire

21 days ago

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

Argus Research

23 days ago

AMPH: What does Argus have to say about AMPH?

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

ACCESS Newswire

a month ago

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

Argus Research

a month ago

AMPH: Raising target price to $31.00

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

StockStory

a month ago

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

ACCESS Newswire

2 months ago

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

StockStory

2 months ago

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

Argus Research

2 months ago

AMPH: Lowering target price to $29.00

Amphastar Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

2 months ago

Amphastar Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey

2 months ago

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Small Cap Pharma Stocks to Buy Now?

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds

Benzinga

2 months ago

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds

GuruFocus.com

2 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q4 2024 Earnings Call Highlights: Revenue Growth and ...

Amphastar (AMPH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

2 months ago

Amphastar (AMPH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates

Zacks

2 months ago

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates

Associated Press Finance

2 months ago

Amphastar: Q4 Earnings Snapshot

Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1%

StockStory

2 months ago

Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1%

Amphastar Pharmaceuticals' (NASDAQ:AMPH) 15% CAGR outpaced the company's earnings growth over the same five-year period

Simply Wall St.

2 months ago

Amphastar Pharmaceuticals' (NASDAQ:AMPH) 15% CAGR outpaced the company's earnings growth over the same five-year period

Earnings To Watch: Amphastar Pharmaceuticals (AMPH) Reports Q4 Results Tomorrow

StockStory

2 months ago

Earnings To Watch: Amphastar Pharmaceuticals (AMPH) Reports Q4 Results Tomorrow

GuruFocus.com

2 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q4 2024 Earnings Report Preview: What To Look For

Argus Research

2 months ago

AMPH: Raising target price to $34.00

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

StockStory

2 months ago

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

ACCESS Newswire

2 months ago

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

StockStory

2 months ago

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

Argus Research

2 months ago

AMPH: Lowering target price to $32.00

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

StockStory

2 months ago

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

StockStory

2 months ago

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

Argus Research

3 months ago

AMPH: Lowering target price to $35.00

MT Newswires

3 months ago

Piper Sandler Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $36 From $66

MT Newswires

3 months ago

BofA Adjusts Price Target on Amphastar Pharmaceuticals to $44 From $46

Argus Research

3 months ago

AMPH: Raising target price to $39.00

Argus Research

3 months ago

AMPH: Lowering target price to $38.00

Argus Research

3 months ago

AMPH: Raising target price to $40.00

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ACCESSWIRE

4 months ago

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Argus Research

4 months ago

AMPH: Lowering target price to $41.00

Argus Research

4 months ago

AMPH: Lowering target price to $43.00

MT Newswires

4 months ago

Amphastar Pharmaceuticals Insider Sold Shares Worth $672,815, According to a Recent SEC Filing

Argus Research

4 months ago

AMPH: Lowering target price to $46.00

Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today?

Simply Wall St.

5 months ago

Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today?

Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options

Zacks

5 months ago

Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options

Argus Research

5 months ago

AMPH: Raising target price to $47.00

Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Insider Monkey

5 months ago

Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Argus Research

5 months ago

AMPH: What does Argus have to say about AMPH?

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

ACCESSWIRE

5 months ago

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

Amphastar initiated with an Equal Weight at Wells Fargo

TipRanks

5 months ago

Amphastar initiated with an Equal Weight at Wells Fargo

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

ACCESSWIRE

5 months ago

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Argus Research

5 months ago

AMPH: Lowering target price to $50.00

Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

6 months ago

Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations

Thomson Reuters StreetEvents

6 months ago

Q3 2024 Amphastar Pharmaceuticals Inc Earnings Call

GuruFocus.com

6 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Call Highlights: Resilient Revenue Growth ...

Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings

Zacks

6 months ago

Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings

Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates

Zacks

6 months ago

Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates

Associated Press Finance

6 months ago

Amphastar: Q3 Earnings Snapshot

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

ACCESSWIRE

6 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

Argus Research

6 months ago

AMPH: What does Argus have to say about AMPH?

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect

GuruFocus.com

6 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect

BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Zacks

6 months ago

BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

6 months ago

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

ACCESSWIRE

6 months ago

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?

Zacks

6 months ago

Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?

Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report?

Zacks

6 months ago

Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report?

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals?

Simply Wall St.

6 months ago

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals?

Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Insider Monkey

6 months ago

Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Argus Research

7 months ago

AMPH: Lowering target price to $49.00

Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options

Zacks

7 months ago

Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options

Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns

Simply Wall St.

7 months ago

Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

GuruFocus.com

8 months ago

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

ACCESSWIRE

8 months ago

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

Argus Research

8 months ago

AMPH: Raising target price to $51.00

Argus Research

8 months ago

AMPH: Raising target price to $48.00

MT Newswires

8 months ago

Amphastar Pharmaceuticals Insider Sold Shares Worth $736,550, According to a Recent SEC Filing

Amphastar Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

8 months ago

Amphastar Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics

Zacks

9 months ago

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics

Amphastar Pharmaceuticals (AMPH) Tops Q2 Earnings and Revenue Estimates

Zacks

9 months ago

Amphastar Pharmaceuticals (AMPH) Tops Q2 Earnings and Revenue Estimates

Associated Press Finance

9 months ago

Amphastar: Q2 Earnings Snapshot

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

ACCESSWIRE

9 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024

ACCESSWIRE

9 months ago

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024

Argus Research

9 months ago

AMPH: Raising target price to $43.00

Argus Research

9 months ago

AMPH: Raising target price to $42.00

Why Amphastar (AMPH) is Poised to Beat Earnings Estimates Again

Zacks

9 months ago

Why Amphastar (AMPH) is Poised to Beat Earnings Estimates Again

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

Zacks

9 months ago

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

Argus Research

9 months ago

AMPH: What does Argus have to say about AMPH?

Argus Research

10 months ago

AMPH: Lowering target price to $39.00

GuruFocus.com

10 months ago

Insider Sale: CFO, EVP & Treasurer William Peters Sells Shares of Amphastar Pharmaceuticals ...

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

GuruFocus.com

10 months ago

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case

Simply Wall St.

a year ago

With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

GlobeNewswire

a year ago

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series

PR Newswire

a year ago

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029

GlobeNewswire

a year ago

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights

GlobeNewswire

a year ago

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights

Shake Shack (SHAK) Rose after Strong Q4 Results

Insider Monkey

a year ago

Shake Shack (SHAK) Rose after Strong Q4 Results

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

GlobeNewswire

a year ago

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

"Green Energy" Brings Charging Piles to Mountain Villages

PR Newswire

a year ago

"Green Energy" Brings Charging Piles to Mountain Villages

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

GlobeNewswire

a year ago

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

Share on Social Networks: